Urabe F. Editorial Comment from Dr Urabe to Telomerase reverse transcriptase promoter
mutation in tumorigenesis of bladder cancer: Evolutionary trajectory by
algorithmic inference from cross-sectional data. Int J Urol 2021 Apr 21. doi: 10.1111/iju.14580.
PMID: 33884688